Impact of prophylactic administration of ciprofloxacin on BK polyoma virus replication.
Koukoulaki
M
M
Apostolou
T
T
Hadjiconstantinou
V
V
Drakopoulos
S
S
D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage*; D001739:BK Virus; D002939:Ciprofloxacin / Q000008:administration & dosage*; D004279:DNA, Viral / Q000097:blood / Q000652:urine; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D027601:Polyomavirus Infections / Q000209:etiology / Q000517:prevention & control* / Q000821:virology; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control* / Q000821:virology; D011446:Prospective Studies; D014412:Tumor Virus Infections / Q000209:etiology / Q000517:prevention & control* / Q000821:virology; D019562:Viral Load; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D004279:DNA, Viral; D002939:Ciprofloxacin